Literature DB >> 21140643

Use of high-performance thin layer chromatography by the American Herbal Pharmacopoeia.

Roy T Upton1.   

Abstract

TLC characterizations are among the key identity tests in most pharmacopoeial monographs. Pharmacopoeial standards are typically used by industry as a basis for meeting QC requirements and current good manufacturing practices (cGMPs). TLC is a relatively low-cost, highly versatile tool for developing specifications for raw materials, as well as for the various preparations for which pharmacopoeial standards are created. In addition to its use in the development of identity tests, TLC is a valuable tool for screening plant samples that pharmacopoeias must review in the development of monographs and botanical reference materials (BRMs). Specifically, HPTLC is the ideal TLC technique for these purposes because of its increased accuracy, reproducibility, and ability to document the results, compared with standard TLC. Because of this, HPTLC technologies are also the most appropriate TLC technique for conformity with GMPs. This article highlights the manner in which HPTLC is used by the American Herbal Pharmacopoeia (AHP) in the development of AHP monograph identity standards, the identification of adulterating species, and the development of AHP-verified BRMs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21140643

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  2 in total

1.  Quantification of adulteration in traded ayurvedic raw drugs employing machine learning approaches with DNA barcode database.

Authors:  Suma Arun Dev; Remya Unnikrishnan; R Jayaraj; P Sujanapal; V Anitha
Journal:  3 Biotech       Date:  2021-10-18       Impact factor: 2.406

2.  Combining DNA and HPTLC profiles to differentiate a pain relief herb, Mallotus repandus, from plants sharing the same common name, "Kho-Khlan".

Authors:  Kannika Thongkhao; Chayapol Tungphatthong; Vipawee Pichetkun; Suthathip Gaewtongliam; Worakorn Wiwatcharakornkul; Suchada Sukrong
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.